The results revealed that the anti-cancer activity of CDTNs was spatially dependent, i.e., PDT was responsible for killing cancer cells in the superficial part of the tumour and the inhibition of the metastasis of residual cells was achieved via reduction in Twist expression with siRNAs. The gene discussed is TWIST1; the disease is cancer.